SG Americas Securities LLC raised its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 255.4% in the 1st quarter, Holdings Channel reports. The institutional investor owned 681,904 shares of the industrial products company’s stock after purchasing an additional 490,040 shares during the quarter. SG Americas Securities LLC’s holdings in Xylem were worth $81,488,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of the business. Smith Salley Wealth Management lifted its stake in shares of Xylem by 1.0% during the 1st quarter. Smith Salley Wealth Management now owns 81,276 shares of the industrial products company’s stock worth $9,712,000 after acquiring an additional 768 shares during the last quarter. Evexia Wealth LLC grew its position in Xylem by 3.8% in the 1st quarter. Evexia Wealth LLC now owns 4,224 shares of the industrial products company’s stock valued at $544,000 after acquiring an additional 154 shares during the last quarter. Forbes J M & Co. LLP increased its stake in Xylem by 0.7% in the first quarter. Forbes J M & Co. LLP now owns 87,217 shares of the industrial products company’s stock worth $10,422,000 after purchasing an additional 601 shares during the period. BI Asset Management Fondsmaeglerselskab A S increased its stake in Xylem by 14.9% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 310,469 shares of the industrial products company’s stock worth $34,550,000 after purchasing an additional 40,365 shares during the period. Finally, Hsbc Holdings PLC lifted its position in shares of Xylem by 2.1% during the fourth quarter. Hsbc Holdings PLC now owns 2,000,691 shares of the industrial products company’s stock worth $272,622,000 after purchasing an additional 41,825 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on XYL shares. UBS Group boosted their target price on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Barclays decreased their price objective on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price objective (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. TD Cowen restated a “hold” rating on shares of Xylem in a research note on Monday, February 23rd. Finally, Citigroup reduced their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $152.77.
Xylem Price Performance
XYL opened at $111.77 on Tuesday. The company has a market capitalization of $26.57 billion, a price-to-earnings ratio of 27.80, a PEG ratio of 1.59 and a beta of 1.05. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. Xylem Inc. has a 12-month low of $105.29 and a 12-month high of $154.27. The business’s fifty day simple moving average is $114.17 and its 200-day simple moving average is $126.01.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the previous year, the company posted $1.03 earnings per share. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, equities research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date is Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem’s payout ratio is currently 42.79%.
Xylem declared that its Board of Directors has initiated a share buyback plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
Insider Activity
In other Xylem news, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.32% of the company’s stock.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Read More
- Five stocks we like better than Xylem
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
